No Data
No Data
ALS Therapy Market Seen Increasing to Nearly $1.3B by 2029
Express News | Ionis Pharmaceuticals Inc : Bernstein Raises Target Price to $44 From $37
Express News | Ionis Pharmaceuticals Inc : Bernstein Raises to Market Perform From Underperform
Flamingo Therapeutics Announces Poster Presentation at EACR 2024 Congress on FLM-7523 (FTX-001), a First-in-Class Inhibitor of the Long Non-Coding RNA MALAT1
LEUVEN, Belgium and STRASBOURG, France and PHILADELPHIA , June 10, 2024 /PRNewswire/ -- Flamingo Therapeutics ("Flamingo") today announced a poster presentation on FLM-7523 (also referred to as FTX-0
TD Cowen Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $54
TD Cowen analyst Yaron Werber maintains $Ionis Pharmaceuticals(IONS.US)$ with a buy rating, and maintains the target price at $54.According to TipRanks data, the analyst has a success rate of 54.0% an
Express News | Ionis Pharmaceuticals Inc : JP Morgan Cuts Target Price to $50 From $55
No Data